Session » Osteoporosis and Metabolic Bone Disease - Clinical Aspects and Pathogenesis Poster

Date: Sunday, November 8, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 353

A Longitudinal Cohort Study of Weekly Teriparatide, Denosmab, and Bisphosphonates for Prevention of Vertebral Fractures in Glucocorticoid-Induced Osteoporosis

9:00AM-11:00AM: Abstract Number: 356

Assessment of the Effect of 12 Months Administration of Denosumab in Patients with Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 354

Association Between Bone and Clinical Parameters in Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 381

Associations Between Vitamin D Insufficiency, Osteoporotic Fractures and Comorbidites

9:00AM-11:00AM: Abstract Number: 350

Atypical Femur Fracture in Rheumatoid Arthritis Patients Treated with Bisphosphonates: A Nested Case-Control Study

9:00AM-11:00AM: Abstract Number: 346

Autoantibodies to Osteoprotegerin Are Independently Associated with Low Hip Bone Mineral Density and Increased Fractures in Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 358

Bone Microstructure Assessed By Hrpqct in Subjects with Hyperuricemia without Arthritis

9:00AM-11:00AM: Abstract Number: 365

Can We Use Bone Turnover Markers As Targets for Antiresorptive Treatment in Postmenopausal Osteoporosis? an Analysis from Two Phase 3 Clinical Trials

9:00AM-11:00AM: Abstract Number: 373

Compared to Non-Users, Current Glucocorticoids Users Have Less Prevalent Fractures at the Same Bone Mass: Results of a Large Cross-Sectional Study

9:00AM-11:00AM: Abstract Number: 349

Comparison Between the American Recommendations and the Japanese Guidelines for Glucocorticoid-Induced Osteoporosis in Japanese Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 366

Cost-Effective Osteoporosis Treatment Intervention Thresholds Based on FRAX in Portugal

9:00AM-11:00AM: Abstract Number: 384

Dental Treatments, Tooth Extraction, and Osteonecrosis at Jaw in Japanese Patients with Rheumatoid Arthritis; Results from the IORRA Cohort Study

9:00AM-11:00AM: Abstract Number: 363

Determination of the Osteoporotic Vertebral Fractures By a New Quantitative Approach: Intervertebral Volume Index

9:00AM-11:00AM: Abstract Number: 359

Diminished Health-Related Quality of Life As Measured By the Short Form-10 in Children with Hypophosphatasia

9:00AM-11:00AM: Abstract Number: 343

Efficacy of Odanacatib in Postmenopausal Women with Osteoporosis: Subgroup Analyses of Data from the Phase 3 Long-Term Odanacatib Fracture Trial

9:00AM-11:00AM: Abstract Number: 377

Hand Bone Impairment By High-Resolution Peripheral Quantitative Computed Tomography in Patients with Diffuse Systemic Sclerosis: Correlation with Clinical Parameters, Quality of Life and Capillaroscopic Findings

9:00AM-11:00AM: Abstract Number: 374

High Prevalence of Osteoporosis and Fractures Is Associated with Abdominal Adiposity and Decreased Muscular Strength in Primary Necrotizing Vasculitides

9:00AM-11:00AM: Abstract Number: 357

Human Parathyroid Hormone for Preventing and Treating Glucocorticoid-Induced Osteoporosis: Cochrane Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 370

Impact of Didactic Lecture on Osteoporosis Screening and Fracture Risk Assessment Among House Staff

9:00AM-11:00AM: Abstract Number: 369

Incidence of Fragility Hip Fractures over 10 Years (2004-13) in Three UK Centres with Reference to Local Fracture Prevention (‘fracture liaison’) Service Activity

9:00AM-11:00AM: Abstract Number: 348

Incidence Rate of Potential Osteonecrosis of the Jaw Among Women with Postmenopausal Osteoporosis Treated with Prolia or Bisphosphonates

9:00AM-11:00AM: Abstract Number: 352

Low Bone Density Is Associated with Atherosclerotic Disease in Patients with Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 360

Massive Elimination of Multinucleated Osteoclasts By Eupatilin Is Due to Dual Inhibition of Transcription and Cytoskeletal Rearrangement

9:00AM-11:00AM: Abstract Number: 371

New Vertebral Fractures after Vertebroplasty: Two Year Results from a Randomised Placebo-Controlled Trial

9:00AM-11:00AM: Abstract Number: 380

Osteoporosis Screening and Treatment of Rheumatoid Arthritis Patients at a Teaching Institution

9:00AM-11:00AM: Abstract Number: 378

Osteoporotic Fragility Tibia/Fibula Fractures Are Not Asociated with a Low Body Mass Index: An Observational Study

9:00AM-11:00AM: Abstract Number: 372

Prevalence of Atypical Fractures in a Tertiary Hospital

9:00AM-11:00AM: Abstract Number: 367

Prevention and Treatment of Bone Loss Following Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 375

RA May Not Confer Addition Risk of Osteoporosis in Male Patients – Results of Cohort Analysis and Literature Review

9:00AM-11:00AM: Abstract Number: 362

Reference Curves of Bone Parameters Obtained By High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) in Healthy Women from 20 to 85 Years Old

9:00AM-11:00AM: Abstract Number: 345

Relationship Between Total Hip BMD T-Score and Incidence of Nonvertebral Fracture with up to 8 Years of Denosumab Treatment

9:00AM-11:00AM: Abstract Number: 344

Results of a Phase 2 Clinical Trial to Evaluate the Effects of Romosozumab in Japanese Women with Postmenopausal Osteoporosis

9:00AM-11:00AM: Abstract Number: 347

Safety Observations with 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab during the Pivotal 3-Year Trial and Subjects Who Crossed over to Denosumab during the Extension

9:00AM-11:00AM: Abstract Number: 361

Sodium Intake and Osteoporosis. Findings from the Women’s Health Initiative

9:00AM-11:00AM: Abstract Number: 383

Stiffness Index Study in Ehler Danlos Syndrome

9:00AM-11:00AM: Abstract Number: 355

The Clinical and Genetic Spectrum of Low Alkaline Phosphatase in Adults

9:00AM-11:00AM: Abstract Number: 368

The Effects of Monitoring on a Quality Indicator for Glucocorticoid–Induced Osteoporosis and Trends of the Drug Variation in a Japanese Hospital

9:00AM-11:00AM: Abstract Number: 376

The Relationships Between Bone Mineral Density and Radiographic Features of Hand or Knee Osteoarthritis in Older Adults: Data from the Dong-Gu Study

9:00AM-11:00AM: Abstract Number: 351

Trabecular Bone Score Is Severely Affected in Male Patients with Chronic Obstructive Pulmonary Disease

9:00AM-11:00AM: Abstract Number: 382

Twelve Months after Osteoporosis Associated Fracture – Has Adequate Therapy Been Initiated?

9:00AM-11:00AM: Abstract Number: 379

Validation of a Short Calcium Intake List to Estimate Daily Dietary Calcium Intake of Patients with Osteoporosis

9:00AM-11:00AM: Abstract Number: 364

Very High Frequency of Fragility Fractures Associated with High-Dose Glucocorticoids in Postmenopausal Women: A Retrospective Study

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].